Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphoma

被引：11

作者：

Adams, Clare M. ^{[1
]}

Mitra, Ramkrishna ^{[1
]}

Vogel, Ashley N. ^{[2
]}

Liu, Jinglan ^{[2
]}

Gong, Jerald Z. ^{[2
]}

Eischen, Christine M. ^{[1
]}

机构：

[1] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA

[2] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA

来源：

LEUKEMIA | 2020年 / 34卷 / 03期

关键词：

REED-STERNBERG CELLS; BRENTUXIMAB VEDOTIN; EXPRESSION;

D O I：

10.1038/s41375-019-0611-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：947 / 952

页数：6

共 15 条

[1] Targeting the Bcl-2 Family in B Cell Lymphoma [J].

Adams, Clare M. ;

Clark-Garvey, Sean ;

Porcu, Pierluigi ;

Eischen, Christine M. .

FRONTIERS IN ONCOLOGY, 2019, 8

[2] Non-Hodgkin and Hodgkin Lymphomas Select for Overexpression of BCLW [J].

Adams, Clare M. ;

Mitra, Ramkrishna ;

Gong, Jerald Z. ;

Eischen, Christine M. .

CLINICAL CANCER RESEARCH, 2017, 23 (22) :7119-7129

[3] Hodgkin Lymphoma: Diagnosis and Treatment [J].

Ansell, Stephen M. .

MAYO CLINIC PROCEEDINGS, 2015, 90 (11) :1574-1583

[4] Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial [J].

Armand, Philippe ;

Engert, Andreas ;

Younes, Anas ;

Fanale, Michelle ;

Santoro, Armando ;

Zinzani, Pier Luigi ;

Timmerman, John M. ;

Collins, Graham P. ;

Ramchandren, Radhakrishnan ;

Cohen, Jonathon B. ;

De Boer, Jan Paul ;

Kuruvilla, John ;

Savage, Kerry J. ;

Trneny, Marek ;

Shipp, Margaret A. ;

Kato, Kazunobu ;

Sumbul, Anne ;

Farsaci, Benedetto ;

Ansell, Stephen M. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) :1428-+

[5] Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma [J].

Connors, J. M. ;

Jurczak, W. ;

Straus, D. J. ;

Ansell, S. M. ;

Kim, W. S. ;

Gallamini, A. ;

Younes, A. ;

Alekseev, S. ;

Illes, A. ;

Picardi, M. ;

Lech-Maranda, E. ;

Oki, Y. ;

Feldman, T. ;

Smolewski, P. ;

Savage, K. J. ;

Bartlett, N. L. ;

Walewski, J. ;

Chen, R. ;

Ramchandren, R. ;

Zinzani, P. L. ;

Cunningham, D. ;

Rosta, A. ;

Josephson, N. C. ;

Song, E. ;

Sachs, J. ;

Liu, R. ;

Jolin, H. A. ;

Huebner, D. ;

Radford, J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (04) :331-344

[6] Targeting BCL-2 in B-cell lymphomas [J].

Davids, Matthew S. .

BLOOD, 2017, 130 (09) :1081-1088

[7]

Herling M, 2003, CLIN CANCER RES, V9, P2114

[8] Targeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737 [J].

Jayanthan, Aarthi ;

Howard, Scott C. ;

Trippett, Tanya ;

Horton, Terzah ;

Whitlock, James A. ;

Daisley, Lara ;

Lewis, Victor ;

Narendran, Aru .

LEUKEMIA & LYMPHOMA, 2009, 50 (07) :1174-1182

[9] Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphoma [J].

Ju, Wei ;

Zhang, Meili ;

Wilson, Kelli M. ;

Petrus, Michael N. ;

Bamford, Richard N. ;

Zhang, Xiaohu ;

Guha, Rajarshi ;

Ferrer, Marc ;

Thomas, Craig J. ;

Waldmann, Thomas A. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (06) :1624-1629

[10] BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell line [J].

Kawasaki, Tsutomu ;

Yokoi, Sana ;

Tsuda, Hitoshi ;

Izumi, Hiroyuki ;

Kozaki, Ken-ichi ;

Aida, Shinsuke ;

Ozeki, Yuichi ;

Yoshizawa, Yasuyuki ;

Imoto, Issei ;

Inazawa, Johji .

CANCER SCIENCE, 2007, 98 (07) :1070-1077

← 1 2 →